Carotid angioplasty and stenting versus redo endarterectomy for recurrent stenosis

Bettendorf, Matthew J.; Mansour, M. Ashraf; Davis, Alan T.; Sugiyama, George T.; Calì, R; Gorsuch, Jill M.; Cuff, Robert

doi:10.1016/j.amjsurg.2006.09.020

Cited by 29 publications

(25 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…4,24,25 CAS has been advocated by some investigators as an alternative to reoperation for post-CEA carotid stenosis. 1,15,19,[26][27][28][29][30][31] Lanzino et al found no major periprocedural neurologic deficits or deaths with 25 CAS on 21 patients. 28 New et al, in a multicenter study of 358 CAS on 338 patients, demonstrated a 3.7% 30-day stroke and death rate with a minor stroke rate of 1.7%.…”

Section: Discussionmentioning

confidence: 97%

“…29 In spite of the positive results for CAS in these studies, only a few reports with a small number of patients have directly compared CAS to redo CEA for post-CEA stenosis. 4,15,[30][31][32] Hobson et al compared 16 cases treated by reoperation with 15 cases treated with CAS over an 8-year period. 15 No 30-day strokes or deaths were reported, and no restenosis or stent occlusion was found in the CAS group over a 7-month follow-up period.…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis

AbuRahma

Abu-Halimah

Hass

et al. 2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 98%

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis

AbuRahma

Abu-Halimah

Hass

et al. 2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Regarding the rate of immediate neurologic and/or fatal complications, our results seem to be similar to those reported in previous series (Table V) 12,13, but also to those published with CAS (Table VI). 10,11,[49][50][51][52][53][54][55][56][57] Indeed, apart from two series of OS with a CMSM of 10.5, and 9.7%, respectively, all reported rates of CMSM were between 0% and 6.3% regardless of the technique used (Tables V and VI).…”

Section: Discussionmentioning

confidence: 94%

Open surgery remains a valid option for the treatment of recurrent carotid stenosis

Coscas

Gruet-Coquet

Couture

et al. 2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

OS for RCS is not a high-risk procedure and provides excellent long-term results, with low rates of tertiary RCS and reinterventions. The comparison between OS and CAS in this indication suffers from the absence of standardized follow-up paradigms after primary OS and the lack of prospective randomized trial comparing the two techniques. Despite these limitations in the available data, we conclude that OS should remain the first line therapy when treatment of RCS is indicated.

show abstract

“…Bettendorf et al 7 relataram em seu trabalho que ACS é um método seguro e efetivo para tratar pacientes com REC e pode se tornar o tratamento de escolha. Outros autores 11,19 têm indicado a ACS nos pacientes considerados de alto risco ou não eligivéis à ECA, baseados nos critérios adotados pelos estudos ACAS e NASCET.…”

Section: Discussionunclassified

“…Entretanto, permanece alta a taxa de morbimortalidade da intervenção cirúrgica na reestenose carotídea 6 . Dessa forma, o tratamento endovascular surge como uma opção cirúrgica à ECA nos pacientes portadores reestenose carotídea 7 .…”

Section: Introductionunclassified

Tratamento endovascular da reestenose carotídea: resultados em curto prazo

Lujan¹,

Lucas²,

Gracio³

et al. 2011

J. vasc. bras.

View full text Add to dashboard Cite

ResumoContexto: O tratamento cirúrgico da reestenose carotídea apresenta alta taxa de lesão neurológica. Contrariamente, o tratamento endovascular da doença obstrutiva carotídea extracraniana tem se tornado mais factível e gradualmente menores taxas de risco cirúrgico vêm sendo reportadas, tornando-se uma opção em situações especiais, e provavelmente poderá ser considerado o tratamento padrão para reestenose carotídea. Objetivos: Avaliar a aplicabilidade, a segurança e a eficácia da angioplastia com o uso do stent (ACS) no tratamento da reestenose carotídea (REC) no intraoperatório e no pós-operatório recente (<30 dias). Métodos: Análise retrospectiva dos pacientes portadores de reestenose carotídea submetidos à angioplastia com stent no período de março 2000 a junho de 2004. Resultados: Foram analisados 19 pacientes com reestenose carotídea. Quatorze pacientes (74%) eram do sexo masculino, com média de idade de 74 anos. Quinze (79%) eram assintomáticos com estenose >80%, enquanto quatro (21%) eram sintomáticos com estenose >70%. Apenas em um paciente não foi utilizado sistema de proteção cerebral. O sucesso técnico foi obtido em todos os casos. Não houve morte ou acidente vascular encefálico no intra ou no pós-operatório recente (30 dias). Conclusão: O tratamento endovascular da reestenose carotídea mostrou-se uma abordagem factível e segura em curto prazo.Palavras-chave: Doenças das artérias carótidas; angioplastia com balão; estenose das carótidas. AbstractContext: The surgical treatment of carotid artery restenosis presents a high risk of nerve injury. On the contrary, endovascular treatment for extracranial carotid artery obstructive disease has become more feasible. Gradually, lower rates of surgical risk have been reported, which makes the treatment a good option in special situations. It may be considered as the standard treatment for carotid artery restenosis. Objective: To evaluate the applicability, safety, and efficacy of the angioplasty with the use of a stent (Carotid Artery Stenting -CAS) for the treatment of carotid artery restenosis, in the intraoperative and early (<30 days) postoperative period. Methods: Retrospective analysis of patients with carotid artery restenosis who have undergone stenting angioplasty from March 2000 to June 2004. Results: Nineteen patients with carotid artery restenosis were analyzed. Fourteen (74%) patients were male, with a mean age of 74 years. Fifteen (79%) patients were asymptomatic, with stenosis >80%, whereas 4 (21%) were symptomatic with stenosis >70%. In only one patient a cerebral protection system was not used. Technical success was achieved in all cases. There was no death or stroke in the intraoperative or the early postoperative period (30 days). Conclusion: Endovascular treatment of carotid artery restenosis seems to be a feasible and safe approach in the short term.

show abstract

Carotid angioplasty and stenting versus redo endarterectomy for recurrent stenosis

Cited by 29 publications

References 25 publications

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis

Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis

Open surgery remains a valid option for the treatment of recurrent carotid stenosis

Tratamento endovascular da reestenose carotídea: resultados em curto prazo

Contact Info

Product

Resources

About